Background illustration for clinical trials search

Paid Clinical Trials Bethesda

Discover 2,414 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,414

Characterization Imaging Instruments in Alcoholics and Non-Alcoholics

for

Alcohol Dependence, Alcohol Drinking, Alcohol-Related Disorders,

Location: Bethesda MD

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Sex: All

Age: 18+

Code: NCT02108080

Recruiting

The Pathogenesis and Natural History of Sjogren's Disease

for

Sjogren's Syndrome, Salivary Gland, Pathogenesis

Location: Bethesda MD

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)

Sex: All

Age: 16 - 70+

Code: NCT01425892

Recruiting

Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome

for

McCune-Albright Syndrome

Location: Bethesda MD

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)

Sex: All

Age: 0 - 70+

Code: NCT00001727

Recruiting

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

for

Metastatic Chondrosarcoma, Locally Advanced Chondrosarcoma,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06176989

Phase2, Recruiting

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

for

Epilepsy

Location: Bethesda MD

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 60

Code: NCT02531880

Phase1, Recruiting

Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

for

Amyotrophic Lateral Sclerosis, Motor Neuron Disease

Location: Bethesda MD

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 70+

Code: NCT07204977

Phase1, Recruiting

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

for

Mesothelioma, Malignant Mesothelioma (MM),

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05960773

Phase2, Recruiting

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

for

Hyper IgE Syndrome From STAT3 Mutation, Job s Syndrome, HIES,

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 12 - 70+

Code: NCT07262983

Phase1, Recruiting

Survey to Determine Incarcerated Persons' Views on Surrogate Decision Making

for

Healthy Volunteers

Location: Bethesda MD

Sponsor: National Institutes of Health Clinical Center (CC)

Sex: All

Age: 18 - 70+

Code: NCT07751731

Recruiting

Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets

for

Meniere's Disease, Enlarged Vestibular Aqueduct Syndrome,

Location: Bethesda MD

Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Sex: All

Age: 18 - 70+

Code: NCT04806282

Recruiting

Evaluation of [11C]ZTP-1 to Image PDE4B

for

Healthy

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 18 - 70+

Code: NCT07625345

Phase1, Recruiting

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

for

Recurrent Glioblastoma,

Location: Bethesda MD

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 70+

Code: NCT07416188

Phase1, Phase2, Recruiting

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

for

Acute Lymphoblastic Leukemia, B-All

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3 - 65

Code: NCT07328503

Phase2, Recruiting

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

for

Myelodysplastic Syndromes

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 70+

Code: NCT06303193

Phase1, Phase2, Recruiting

BPL-1357 Against H1N1 Influenza Virus Challenge

for

Influenza, Human

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 55

Code: NCT07215858

Phase2, Recruiting

NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors

for

Very Rare Tumors, Very Rare Cancers, Other Solid Tumors,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 70+

Code: NCT07489378

Recruiting

Turner Syndrome: Genetic Considerations

for

Genetic

Location: Bethesda MD

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: All

Age: 0 - 70+

Code: NCT07502586

Recruiting

DDAVP for Pituitary Adenoma

for

Cushing's Disease, Pituitary Adenoma

Location: Bethesda MD

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 8 - 70+

Code: NCT04569591

Recruiting

Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)

for

Kaposi Sarcoma

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT07308886

Phase2, Recruiting

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

for

Neurofibromatosis Type 1

Location: Bethesda MD, Washington D.C. DC

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 70+

Code: NCT06507748

Recruiting

Paid Clinical Trials Bethesda

Filter results

Characterization Imaging Instruments in Alcoholics and Non-Alcoholics

The Pathogenesis and Natural History of Sjogren's Disease

Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

Interested in new trials?

Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

Survey to Determine Incarcerated Persons' Views on Surrogate Decision Making

Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets

Evaluation of [11C]ZTP-1 to Image PDE4B

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

BPL-1357 Against H1N1 Influenza Virus Challenge

NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors

Turner Syndrome: Genetic Considerations

DDAVP for Pituitary Adenoma

Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)